 - Arm II: Patients undergo leukapheresis to obtain autologous lymphokine-activated killer LAK cells, followed 3-7 days later by therapeutic craniotomy. The autologous LAK cells are then instilled into the tumor bed cavity at the time of therapeutic craniotomy. 